Immediate Impact
26 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
Works of Timur Cerić being referenced
1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Timur Cerić | 67 | 45 | 39 | 23 | 158 | |
| Elizabeth Blessing Elimimian | 91 | 17 | 40 | 20 | 175 | |
| Admire Matsika | 32 | 49 | 28 | 16 | 136 | |
| Lucy Guerra | 120 | 28 | 33 | 22 | 223 | |
| Lindsay F. Petersen | 70 | 45 | 25 | 17 | 155 | |
| Mihai Vasile Marinca | 131 | 56 | 62 | 30 | 234 | |
| Rosa Vattiato | 113 | 40 | 18 | 25 | 167 | |
| Odair Carlito Michelin | 41 | 32 | 41 | 16 | 185 | |
| Mathias Warm | 86 | 29 | 27 | 20 | 177 | |
| Jack Junjie Chan | 115 | 50 | 43 | 24 | 178 | |
| Blair McNamara | 44 | 26 | 23 | 33 | 214 |
All Works
Login with ORCID to disown or claim papers
Loading papers...